Gensight Biologics SA
PAR:SIGHT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gensight Biologics SA
PAR:SIGHT
|
FR |
|
Fosterville South Exploration Ltd
XTSX:FSX
|
CA |
|
Quadrant Televentures Ltd
BSE:511116
|
IN |
|
Cuentas Inc
OTC:CUEN
|
US |
|
Telus International Cda Inc
TSX:TIXT
|
CA |
|
ECN Capital Corp
TSX:ECN
|
CA |
|
Capstone Copper Corp
TSX:CS
|
CA |
|
Cdon AB
OTC:CDOAF
|
SE |
|
Playstudios Inc
NASDAQ:MYPS
|
US |
|
Starcore International Mines Ltd
TSX:SAM
|
CA |
|
S
|
STP&I PCL
SET:STPI
|
TH |
|
Stericycle Inc
NASDAQ:SRCL
|
US |
|
C
|
C&C International Co Ltd
KOSDAQ:352480
|
KR |
|
S
|
Srinanaporn Marketing PCL
SET:SNNP
|
TH |
|
SUI Group Holdings Ltd
NASDAQ:SUIG
|
US |
|
Vistance Networks Inc
NASDAQ:VISN
|
US |
Wall Street
Price Targets
SIGHT Price Targets Summary
Gensight Biologics SA
According to Wall Street analysts, the average 1-year price target for
SIGHT
is 0.4386 EUR
with a low forecast of 0.404 EUR and a high forecast of 0.483 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SIGHT's stock price target?
Price Target
0.4386
EUR
According to Wall Street analysts, the average 1-year price target for
SIGHT
is 0.4386 EUR
with a low forecast of 0.404 EUR and a high forecast of 0.483 EUR.
What is Gensight Biologics SA's Revenue forecast?
Projected CAGR
174%
The
compound annual growth rate
of Gensight Biologics SA's revenue for the next 3 years is
174%.
